Developing a novel antibiotic for bacterial pneumonia.
Industry: Health Care
First Day Return: +29.2%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/18/2015 |
Offer Price | $10.25 |
Price Range $10.50 - $10.50 | |
Offer Shares (mm) | 9.0 |
Deal Size ($mm) | $92 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/17/2015 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $92 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Vienna, Austria |
Founded | 2005 |
Employees at IPO | 41 |
Website www.nabriva.com |